ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0517

Gut Microbiota Dysbiosis and Clinical Predictors of Fatigue in Primary Sjögren’s Syndrome: A Multi-Omics Study

Qiguo Cui1, Pan Wang2, Bin Zhou1 and QIn Huang3, 1Southern Medical Univercity Nanfang Hospital, guang zhou, China (People's Republic), 2southern medical university Nanfang Hospital, Guangzhou, China (People's Republic), 3Nanfang Hospital, Guangzhou, China (People's Republic)

Meeting: ACR Convergence 2025

Keywords: Cohort Study, Fatigue, microbiome, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0506–0521) Sjögren’s Disease – Basic & Clinical Science Poster I: Etiology, Pathogenesis, Diagnosis

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Fatigue affects 70% of primary Sjögren’s syndrome (pSS) patients, but its mechanisms remain unclear. We investigated clinical predictors and gut microbiota associations in pSS-related fatigue.

Methods: 196 pSS patients were stratified by ESSPRI and Profile of Fatigue (ProF) scores. Univariate/multivariable logistic regression identified fatigue predictors. Fecal samples from 57 patients underwent 16S rRNA sequencing.

Results: 1.ESSPRI fatigue dimension: Fatigue was associated with SAS (OR = 1.06, 95% CI: 1.01–1.12, p = 0.032) and IFN-γ (OR = 1.72, 95% CI: 1.34–2.2, p < 0.001). Fatigue improvement was linked to the use of total glucosides of paeony (OR = 1.98, 95% CI: 1.03–3.81, p = 0.041) and IgG levels (OR = 0.94, 95% CI: 0.90–0.99, p = 0.014).2.Profile of Fatigue-Somatic Dimension: Fatigue was associated with SAS (OR = 1.10, 95% CI: 1.04–1.16, p < 0.001), IFN-γ (OR = 1.37, 95% CI: 1.12–1.68, p = 0.003), and anti-SSB antibodies (OR = 2.72, 95% CI: 1.39–5.69, p = 0.008). Fatigue improvement correlated with total glucosides of paeony use (OR=2.32, 95%CI 1.07 ~ 5.01, p=0.032) and CH50 levels (OR=1.06, 95%CI 1.03-1.10, p<0.001).3.Profile of Fatigue-Mental Dimension: Fatigue was associated with SAS (OR = 1.06, 95% CI: 1.01–1.11, p = 0.019) and SDS (OR = 1.05, 95% CI: 1.01–1.09, p = 0.016). Fatigue improvement was linked to male sex (OR = 0.10, 95% CI: 0.01–0.85, p = 0.035), hematologic involvement (OR = 0.44, 95% CI: 0.21–0.92, p = 0.029), CH50 (OR = 1.04, 95% CI: 1.01–1.07, p = 0.019), and anti-SSB antibody positivity (OR = 0.45, 95% CI: 0.21–0.95, p = 0.036).4.16S rRNA sequencing revealed significant differences in α- and β-diversity of gut microbiota between fatigue and non-fatigue groups. Escherichia-Shigella and Streptococcus were significantly enriched in the fatigue group, and their abundances showed a strong positive correlation with fatigue severity scores. In contrast, Ruminococcus torques group, Faecalibacterium, and Subdoligranulum were predominantly enriched in the non-fatigue group, with their abundances negatively correlated with fatigue scores.

Conclusion: This study, through a multi-dimensional assessment framework encompassing the ESSPRI fatigue dimension and the ProF physical/mental fatigue subscales, revealed that SAS, SDS, IFN-γ, and anti-SSB antibodies are associated with pSS-related fatigue. Total glucosides of paeony use, IgG levels, CH50 levels, sex(male), anti-SSB antibody status, and hematologic involvement significantly influence fatigue improvement in pSS patients. Gut microbiota may contribute to the pathogenesis of pSS-related fatigue. These findings provide critical insights into the mechanisms underlying pSS-related fatigue and suggest novel strategies for diagnosis and therapeutic intervention.

Supporting image 1Binary logistic regression based on Profile of Fatigue-Somatic improvement grouping

Supporting image 2Binary logistic regression based on Profile of Fatigue-Mental improvement grouping

Supporting image 3LEfSe analysis of gut microbiota between two groups


Disclosures: Q. Cui: None; P. Wang: None; B. Zhou: None; Q. Huang: None.

To cite this abstract in AMA style:

Cui Q, Wang P, Zhou B, Huang Q. Gut Microbiota Dysbiosis and Clinical Predictors of Fatigue in Primary Sjögren’s Syndrome: A Multi-Omics Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/gut-microbiota-dysbiosis-and-clinical-predictors-of-fatigue-in-primary-sjogrens-syndrome-a-multi-omics-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gut-microbiota-dysbiosis-and-clinical-predictors-of-fatigue-in-primary-sjogrens-syndrome-a-multi-omics-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology